SOX18 and Kaposi's sarcoma: We recently reported high SOX18 expression in KS tumors and that SOX18 was required to maintain the high number of intracellular KSHV genome copies in infected LECs, suggesting SOX18 as an attractive therapeutic target for KS [12].